Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu‐opioid receptor-Reference-Cited by-同舟云学术

Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu‐opioid receptor

Published:2021-05-26 Issue:11 Volume:236 Page:7698-7710
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Gorur Aysegul¹²^ORCID,Patiño Miguel³,Shi Ted¹²,Corrales German¹,Takahashi Hideaki⁴,Rangel Roberto⁴,Gleber‐Netto Frederico O.⁴,Pickering Curtis⁴,Myers Jeffrey N.²⁴,Cata Juan P.¹²

Affiliation:

1. Department of Anesthesiology and Perioperative Medicine The University of Texas MD Anderson Cancer Center Houston Texas USA

2. Anesthesiology and Surgical Oncology Research Group Houston Texas USA

3. Department of Anesthesiology, Massachusetts General Hospital Harvard University Boston Massachusetts USA

4. Department of Head and Neck Surgery The University of Texas MD Anderson Cancer Center Houston Texas USA

Funder

University of Texas MD Anderson Cancer Center

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.30421

Reference32 articles.

1. In vitro and in vivo experimental models as tools to investigate the efficacy of antineoplastic drugs on urinary bladder cancer;Arantes‐Rodrigues R.;Anticancer Research,2013

2. The effects of naloxone on human breast cancer progression: in vitro and in vivo studies on MDA.MB231 cells

3. Intraoperative opioids use for laryngeal squamous cell carcinoma surgery and recurrence: a retrospective study

4. Passive diffusion of naltrexone into human and animal cells and upregulation of cell proliferation

5. Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Small Molecular Agents against Oral Cancer;Molecules;2024-04-03

2. The Role of Opioid Receptors in Cancer;Advanced Biology;2023-05-02

3. A hybrid mechanistic machine learning approach to model industrial network dynamics for sustainable design of emerging carbon capture and utilization technologies;Sustainable Energy & Fuels;2023

4. Association of Mu-Opioid Receptor Expression With Long-Term Survival and Perineural Nerve Invasion in Patients Undergoing Surgery for Ovarian Cancer;Frontiers in Oncology;2022-07-07

5. Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction?;Current Oncology Reports;2022-06-01